American Journal of Cancer Research-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2216785, encodeId=840c2216e8566, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：两个多月修回，没有给修稿时间，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e909137780, createdName=ms4000000731438466, createdTime=Thu Jul 25 14:34:59 CST 2024, time=2024-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2248897, encodeId=d3da224889e5a, content=最近有没有一审修回后二审比较久的啊，我的超过1个月了，发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/39439D60C1618DE672C0C92941D70C8F/100, createdBy=8eda2086410, createdName=ms7625496543595098, createdTime=Mon Jan 20 14:34:32 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211662, encodeId=f0482211662af, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：综述比较好发，刚发了一篇，胆管癌的精准治疗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:32:47 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2244640, encodeId=d9d122446409c, content=Review投稿两个月了，还是under review……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Tue Dec 24 12:37:38 CST 2024, time=2024-12-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2222254, encodeId=bcfc222225470, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2个半月，拒了，能不能早点拒啊，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49a96321390, createdName=1019283_0108, createdTime=Sat Aug 24 21:07:03 CST 2024, time=2024-08-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224175, encodeId=d38822241e563, content=偏重的研究方向：肿瘤 经验分享：投完之后没收到邮件的扣个1，别点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Thu Sep 05 12:08:19 CST 2024, time=2024-09-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省)]

2024-07-25 ms4000000731438466 来自天津

审稿速度:3.0
偏重的研究方向：肿瘤
经验分享：两个多月修回，没有给修稿时间，正常吗？

129 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216785, encodeId=840c2216e8566, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：两个多月修回，没有给修稿时间，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e909137780, createdName=ms4000000731438466, createdTime=Thu Jul 25 14:34:59 CST 2024, time=2024-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2248897, encodeId=d3da224889e5a, content=最近有没有一审修回后二审比较久的啊，我的超过1个月了，发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/39439D60C1618DE672C0C92941D70C8F/100, createdBy=8eda2086410, createdName=ms7625496543595098, createdTime=Mon Jan 20 14:34:32 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211662, encodeId=f0482211662af, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：综述比较好发，刚发了一篇，胆管癌的精准治疗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:32:47 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2244640, encodeId=d9d122446409c, content=Review投稿两个月了，还是under review……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Tue Dec 24 12:37:38 CST 2024, time=2024-12-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2222254, encodeId=bcfc222225470, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2个半月，拒了，能不能早点拒啊，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49a96321390, createdName=1019283_0108, createdTime=Sat Aug 24 21:07:03 CST 2024, time=2024-08-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224175, encodeId=d38822241e563, content=偏重的研究方向：肿瘤 经验分享：投完之后没收到邮件的扣个1，别点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Thu Sep 05 12:08:19 CST 2024, time=2024-09-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省)]

2025-01-20 ms7625496543595098 来自北京

最近有没有一审修回后二审比较久的啊，我的超过1个月了，发邮件问也不回复。

99 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216785, encodeId=840c2216e8566, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：两个多月修回，没有给修稿时间，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e909137780, createdName=ms4000000731438466, createdTime=Thu Jul 25 14:34:59 CST 2024, time=2024-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2248897, encodeId=d3da224889e5a, content=最近有没有一审修回后二审比较久的啊，我的超过1个月了，发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/39439D60C1618DE672C0C92941D70C8F/100, createdBy=8eda2086410, createdName=ms7625496543595098, createdTime=Mon Jan 20 14:34:32 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211662, encodeId=f0482211662af, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：综述比较好发，刚发了一篇，胆管癌的精准治疗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:32:47 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2244640, encodeId=d9d122446409c, content=Review投稿两个月了，还是under review……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Tue Dec 24 12:37:38 CST 2024, time=2024-12-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2222254, encodeId=bcfc222225470, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2个半月，拒了，能不能早点拒啊，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49a96321390, createdName=1019283_0108, createdTime=Sat Aug 24 21:07:03 CST 2024, time=2024-08-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224175, encodeId=d38822241e563, content=偏重的研究方向：肿瘤 经验分享：投完之后没收到邮件的扣个1，别点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Thu Sep 05 12:08:19 CST 2024, time=2024-09-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省)]

2024-06-26 shademei 来自山西

审稿速度:2.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤
经验分享：综述比较好发，刚发了一篇，胆管癌的精准治疗

239 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216785, encodeId=840c2216e8566, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：两个多月修回，没有给修稿时间，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e909137780, createdName=ms4000000731438466, createdTime=Thu Jul 25 14:34:59 CST 2024, time=2024-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2248897, encodeId=d3da224889e5a, content=最近有没有一审修回后二审比较久的啊，我的超过1个月了，发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/39439D60C1618DE672C0C92941D70C8F/100, createdBy=8eda2086410, createdName=ms7625496543595098, createdTime=Mon Jan 20 14:34:32 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211662, encodeId=f0482211662af, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：综述比较好发，刚发了一篇，胆管癌的精准治疗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:32:47 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2244640, encodeId=d9d122446409c, content=Review投稿两个月了，还是under review……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Tue Dec 24 12:37:38 CST 2024, time=2024-12-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2222254, encodeId=bcfc222225470, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2个半月，拒了，能不能早点拒啊，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49a96321390, createdName=1019283_0108, createdTime=Sat Aug 24 21:07:03 CST 2024, time=2024-08-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224175, encodeId=d38822241e563, content=偏重的研究方向：肿瘤 经验分享：投完之后没收到邮件的扣个1，别点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Thu Sep 05 12:08:19 CST 2024, time=2024-09-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省)]

2024-12-24 1251953cm97(暂无昵称) 来自辽宁省

Review投稿两个月了，还是under review……

109 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216785, encodeId=840c2216e8566, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：两个多月修回，没有给修稿时间，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e909137780, createdName=ms4000000731438466, createdTime=Thu Jul 25 14:34:59 CST 2024, time=2024-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2248897, encodeId=d3da224889e5a, content=最近有没有一审修回后二审比较久的啊，我的超过1个月了，发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/39439D60C1618DE672C0C92941D70C8F/100, createdBy=8eda2086410, createdName=ms7625496543595098, createdTime=Mon Jan 20 14:34:32 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211662, encodeId=f0482211662af, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：综述比较好发，刚发了一篇，胆管癌的精准治疗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:32:47 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2244640, encodeId=d9d122446409c, content=Review投稿两个月了，还是under review……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Tue Dec 24 12:37:38 CST 2024, time=2024-12-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2222254, encodeId=bcfc222225470, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2个半月，拒了，能不能早点拒啊，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49a96321390, createdName=1019283_0108, createdTime=Sat Aug 24 21:07:03 CST 2024, time=2024-08-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224175, encodeId=d38822241e563, content=偏重的研究方向：肿瘤 经验分享：投完之后没收到邮件的扣个1，别点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Thu Sep 05 12:08:19 CST 2024, time=2024-09-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省)]

2023-05-24 gaogao 来自广东省

审稿速度:2.0
偏重的研究方向：肿瘤
经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友

195 38 举报

展开38条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216785, encodeId=840c2216e8566, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：两个多月修回，没有给修稿时间，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e909137780, createdName=ms4000000731438466, createdTime=Thu Jul 25 14:34:59 CST 2024, time=2024-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2248897, encodeId=d3da224889e5a, content=最近有没有一审修回后二审比较久的啊，我的超过1个月了，发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/39439D60C1618DE672C0C92941D70C8F/100, createdBy=8eda2086410, createdName=ms7625496543595098, createdTime=Mon Jan 20 14:34:32 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211662, encodeId=f0482211662af, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：综述比较好发，刚发了一篇，胆管癌的精准治疗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:32:47 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2244640, encodeId=d9d122446409c, content=Review投稿两个月了，还是under review……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Tue Dec 24 12:37:38 CST 2024, time=2024-12-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2222254, encodeId=bcfc222225470, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2个半月，拒了，能不能早点拒啊，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49a96321390, createdName=1019283_0108, createdTime=Sat Aug 24 21:07:03 CST 2024, time=2024-08-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224175, encodeId=d38822241e563, content=偏重的研究方向：肿瘤 经验分享：投完之后没收到邮件的扣个1，别点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Thu Sep 05 12:08:19 CST 2024, time=2024-09-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省)]

2024-08-24 1019283_0108 来自吉林省

审稿速度:3.0 | 投稿命中率:50.0
经验分享：2个半月，拒了，能不能早点拒啊，无语

130 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216785, encodeId=840c2216e8566, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：两个多月修回，没有给修稿时间，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e909137780, createdName=ms4000000731438466, createdTime=Thu Jul 25 14:34:59 CST 2024, time=2024-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2248897, encodeId=d3da224889e5a, content=最近有没有一审修回后二审比较久的啊，我的超过1个月了，发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/39439D60C1618DE672C0C92941D70C8F/100, createdBy=8eda2086410, createdName=ms7625496543595098, createdTime=Mon Jan 20 14:34:32 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211662, encodeId=f0482211662af, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：综述比较好发，刚发了一篇，胆管癌的精准治疗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:32:47 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2244640, encodeId=d9d122446409c, content=Review投稿两个月了，还是under review……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Tue Dec 24 12:37:38 CST 2024, time=2024-12-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2222254, encodeId=bcfc222225470, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2个半月，拒了，能不能早点拒啊，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49a96321390, createdName=1019283_0108, createdTime=Sat Aug 24 21:07:03 CST 2024, time=2024-08-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224175, encodeId=d38822241e563, content=偏重的研究方向：肿瘤 经验分享：投完之后没收到邮件的扣个1，别点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Thu Sep 05 12:08:19 CST 2024, time=2024-09-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省)]

2024-03-08 148ca721m03暂无昵称来自湖北省

2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊

222 9 举报

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216785, encodeId=840c2216e8566, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：两个多月修回，没有给修稿时间，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e909137780, createdName=ms4000000731438466, createdTime=Thu Jul 25 14:34:59 CST 2024, time=2024-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2248897, encodeId=d3da224889e5a, content=最近有没有一审修回后二审比较久的啊，我的超过1个月了，发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/39439D60C1618DE672C0C92941D70C8F/100, createdBy=8eda2086410, createdName=ms7625496543595098, createdTime=Mon Jan 20 14:34:32 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211662, encodeId=f0482211662af, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：综述比较好发，刚发了一篇，胆管癌的精准治疗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:32:47 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2244640, encodeId=d9d122446409c, content=Review投稿两个月了，还是under review……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Tue Dec 24 12:37:38 CST 2024, time=2024-12-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2222254, encodeId=bcfc222225470, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2个半月，拒了，能不能早点拒啊，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49a96321390, createdName=1019283_0108, createdTime=Sat Aug 24 21:07:03 CST 2024, time=2024-08-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224175, encodeId=d38822241e563, content=偏重的研究方向：肿瘤 经验分享：投完之后没收到邮件的扣个1，别点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Thu Sep 05 12:08:19 CST 2024, time=2024-09-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省)]

2024-09-05 ms7000000417591078 来自天津

偏重的研究方向：肿瘤
经验分享：投完之后没收到邮件的扣个1，别点赞

124 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216785, encodeId=840c2216e8566, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：两个多月修回，没有给修稿时间，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e909137780, createdName=ms4000000731438466, createdTime=Thu Jul 25 14:34:59 CST 2024, time=2024-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2248897, encodeId=d3da224889e5a, content=最近有没有一审修回后二审比较久的啊，我的超过1个月了，发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/39439D60C1618DE672C0C92941D70C8F/100, createdBy=8eda2086410, createdName=ms7625496543595098, createdTime=Mon Jan 20 14:34:32 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211662, encodeId=f0482211662af, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：综述比较好发，刚发了一篇，胆管癌的精准治疗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:32:47 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2244640, encodeId=d9d122446409c, content=Review投稿两个月了，还是under review……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Tue Dec 24 12:37:38 CST 2024, time=2024-12-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2222254, encodeId=bcfc222225470, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2个半月，拒了，能不能早点拒啊，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49a96321390, createdName=1019283_0108, createdTime=Sat Aug 24 21:07:03 CST 2024, time=2024-08-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224175, encodeId=d38822241e563, content=偏重的研究方向：肿瘤 经验分享：投完之后没收到邮件的扣个1，别点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Thu Sep 05 12:08:19 CST 2024, time=2024-09-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省)]

2023-12-31 随后来自湖北省

投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投

182 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2216785, encodeId=840c2216e8566, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：两个多月修回，没有给修稿时间，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e909137780, createdName=ms4000000731438466, createdTime=Thu Jul 25 14:34:59 CST 2024, time=2024-07-25, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2248897, encodeId=d3da224889e5a, content=最近有没有一审修回后二审比较久的啊，我的超过1个月了，发邮件问也不回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/39439D60C1618DE672C0C92941D70C8F/100, createdBy=8eda2086410, createdName=ms7625496543595098, createdTime=Mon Jan 20 14:34:32 CST 2025, time=2025-01-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2211662, encodeId=f0482211662af, content=审稿速度:2.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤 经验分享：综述比较好发，刚发了一篇，胆管癌的精准治疗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=239, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe1e1686453, createdName=shademei, createdTime=Wed Jun 26 00:32:47 CST 2024, time=2024-06-26, status=1, ipAttribution=山西), GetPortalCommentsPageByObjectIdResponse(id=2244640, encodeId=d9d122446409c, content=Review投稿两个月了，还是under review……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=45e52538960, createdName=1251953cm97(暂无昵称), createdTime=Tue Dec 24 12:37:38 CST 2024, time=2024-12-24, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2138813, encodeId=32aa2138813fa, content=审稿速度:2.0 偏重的研究方向：肿瘤 经验分享：有近期投稿的朋友们吗有没有一审修回后杂志要求润色的朋友 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed May 24 14:02:10 CST 2023, time=2023-05-24, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2222254, encodeId=bcfc222225470, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2个半月，拒了，能不能早点拒啊，无语, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49a96321390, createdName=1019283_0108, createdTime=Sat Aug 24 21:07:03 CST 2024, time=2024-08-24, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2192065, encodeId=a9272192065d0, content=2024-1-10投稿至今两个多月还在under review 之前邮件说是审稿4-8周的啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=222, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da775330396, createdName=148ca721m03暂无昵称, createdTime=Fri Mar 08 12:47:13 CST 2024, time=2024-03-08, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224175, encodeId=d38822241e563, content=偏重的研究方向：肿瘤 经验分享：投完之后没收到邮件的扣个1，别点赞, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608c8262272, createdName=ms7000000417591078, createdTime=Thu Sep 05 12:08:19 CST 2024, time=2024-09-05, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2178324, encodeId=c1c421e832465, content=投稿三四个月，不知道是否送审，发邮件也不回。垃圾期刊，千万别投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d8ca5307906, createdName=随后, createdTime=Sun Dec 31 14:40:32 CST 2023, time=2023-12-31, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2198484, encodeId=f76d21984843d, content=偏重的研究方向：肿瘤 经验分享：目前这个杂志一审需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231020/9a7cba30b8b140c78120c7acf9c0c8c2/5b6deb3cbcd44c788f0bddc9c63fbd64.jpg, createdBy=c7195518808, createdName=值班室禁止学习, createdTime=Sun Apr 14 20:17:40 CST 2024, time=2024-04-14, status=1, ipAttribution=四川省)]

2024-04-14 值班室禁止学习来自四川省

偏重的研究方向：肿瘤
经验分享：目前这个杂志一审需要多久？

210 1 举报

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务